Clarify Health Lands $57M in Quest to Optimize Healthcare

Clarify Health Solutions, which aims to optimize healthcare with cutting-edge technologies, has raised $57 million in Series B funding, according to an announcement.

The move follows what the company described as a “rapid customer expansion” over this calendar year, noting that its cloud-based software programs are used in more than 5,000 healthcare organizations. Ultimately, Clarify Health Solutions hopes to personalize and enhance all areas of healthcare, from the clinical to the financial, through predictive analytics, machine learning and medical expertise.

>> READ: Fighting Cancer with CAR T and Big Data

“We are entering a new era where technology can help us to reimagine care deliver,” said Jean Drouin, M.D., MBA, CEO and co-founder of Clarify and a member of this publication’s editorial advisory board. “We have accepted for far too long that an accessible, service-oriented and customer-centric experience is simply unattainable in healthcare.”

Clarify, however, hopes to change that through its three primary solutions: Clarify Care Prism, which leverages machine-learning analytics to bolster value-based care and more; Clarify Care Pilot, a real-time patient engagement platform; and Clarify Care Connect, which helps clinicians keep tabs on and guide patients.

Clarify serves health systems, insurers and pharma companies to improve care delivery. Its predictive analytics and machine learning have matured on a data set of more than 20 terabytes of clinical, claims and other information. The goal of all this tech: Clinicians can make the right treatment decisions, patients get the “visibility and guidance” they need, and everyone benefits from value-based payments.

The company’s work attracted the global investor KKR, who led Clarify’s $57 million round through its Health Care Strategic Growth Fund.

Clarify leaders plan to use the money to hire more employees, buy more data and accelerate work on the company’s digital care guidance platform.

Underpinning the company is not just the technological blossoming occurring in healthcare but also the shift to value-based care.

“I would not have left a job and a career I was very happy with if I had not had some amount of conviction that the change in payment model from fee-for-service to value-based … would finally create the forcing function or the impetus for providers and payers to invest in the same kind of platforms we see in other industries,” Drouin told Healthcare Analytics News™ last year.

Get the best insights in healthcare analytics directly to your inbox.

Related

Clarify CEO on Apps, Data Silos and the Future of Value-Based Analytics

Healthcare’s Biggest Data and Analytics Challenges in 2018

Cota Raises $40M in Series C Funding Round